BR Trials-Ensaios Clinicos e Consultoria

São Paulo 05003-090

7 studies enrolling now · 13 studies all time

What they study most

Alzheimer's Disease Psychosis, Atherosclerotic Cardiovascular Disease (ASCVD), Bipolar Disorder, Cardiovascular Diseases, Chronic Kidney Disease, Chronic Kidney Disease (CKD), Colitis, Ulcerative, Crohn Disease, Depressive Disorder, Major, OSA, Obesity, Obstructive Sleep Apnea

Studies at this site

• A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease — Recruiting now
• A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease — Recruiting now
• A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1) — Recruiting now
• A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight — Recruiting now
• A Study of Brenipatide in Adult Participants With Major Depressive Disorder — Recruiting now
• LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• ACP-204 in Adults With Alzheimer's Disease Psychosis — Recruiting now
• ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study — Enrolling by invitation
• The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) — Running, not enrolling
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity — Running, not enrolling
• A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight — Running, not enrolling
• Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea — Completed